139 related articles for article (PubMed ID: 18336395)
1. National Cancer Institute-United States strategy regarding intraperitoneal chemotherapy for ovarian cancer.
Trimble EL; Christian MC
Int J Gynecol Cancer; 2008; 18 Suppl 1():26-8. PubMed ID: 18336395
[TBL] [Abstract][Full Text] [Related]
2. Treatment of ovarian cancer with intraperitoneal chemotherapy.
Hydzik C
Oncology (Williston Park); 2009 Oct; 23(11 Suppl Nurse Ed):15-20. PubMed ID: 19856603
[TBL] [Abstract][Full Text] [Related]
3. Principles and practice of intraperitoneal chemotherapy for ovarian cancer.
Fujiwara K; Armstrong D; Morgan M; Markman M
Int J Gynecol Cancer; 2007; 17(1):1-20. PubMed ID: 17291226
[TBL] [Abstract][Full Text] [Related]
4. Principle and evolving role of intraperitoneal chemotherapy in ovarian cancer.
Fujiwara K; Nagao S; Aotani E; Hasegawa K
Expert Opin Pharmacother; 2013 Sep; 14(13):1797-806. PubMed ID: 23915009
[TBL] [Abstract][Full Text] [Related]
5. ACOG Committee Opinion No. 396. Intraperitoneal chemotherapy for ovarian cancer.
American College of Obstetricians and Gynecologists
Obstet Gynecol; 2008 Jan; 111(1):249. PubMed ID: 18165421
[TBL] [Abstract][Full Text] [Related]
6. Implementation of intraperitoneal chemotherapy for the treatment of ovarian cancer.
Hydzik C
Clin J Oncol Nurs; 2007 Apr; 11(2):221-5. PubMed ID: 17573271
[TBL] [Abstract][Full Text] [Related]
7. Intraperitoneal chemotherapy: implications beyond ovarian cancer.
Marin K; Oleszewski K; Muehlbauer P
Clin J Oncol Nurs; 2007 Dec; 11(6):881-9. PubMed ID: 18063547
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer.
Fairfield KM; Murray K; LaChance JA; Wierman HR; Earle CC; Trimble EL; Warren JL
Gynecol Oncol; 2014 Sep; 134(3):473-7. PubMed ID: 24952367
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses.
Elit L; Oliver TK; Covens A; Kwon J; Fung MF; Hirte HW; Oza AM
Cancer; 2007 Feb; 109(4):692-702. PubMed ID: 17238181
[TBL] [Abstract][Full Text] [Related]
10. Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial.
Rothenberg ML; Liu PY; Braly PS; Wilczynski SP; Hannigan EV; Wadler S; Stuart G; Jiang C; Markman M; Alberts DS
J Clin Oncol; 2003 Apr; 21(7):1313-9. PubMed ID: 12663720
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer.
Hess LM; Benham-Hutchins M; Herzog TJ; Hsu CH; Malone DC; Skrepnek GH; Slack MK; Alberts DS
Int J Gynecol Cancer; 2007; 17(3):561-70. PubMed ID: 17504373
[TBL] [Abstract][Full Text] [Related]
12. Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer.
Wright AA; Cronin A; Milne DE; Bookman MA; Burger RA; Cohn DE; Cristea MC; Griggs JJ; Keating NL; Levenback CF; Mantia-Smaldone G; Matulonis UA; Meyer LA; Niland JC; Weeks JC; O'Malley DM
J Clin Oncol; 2015 Sep; 33(26):2841-7. PubMed ID: 26240233
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
Almadrones L
Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective.
Rao G; Crispens M; Rothenberg ML
J Clin Oncol; 2007 Jul; 25(20):2867-72. PubMed ID: 17617517
[TBL] [Abstract][Full Text] [Related]
15. Intraperitoneal chemotherapy for patients with advanced ovarian cancer: a review of the evidence and standards for the delivery of care.
Fung-Kee-Fung M; Provencher D; Rosen B; Hoskins P; Rambout L; Oliver T; Gotlieb W; Covens A;
Gynecol Oncol; 2007 Jun; 105(3):747-56. PubMed ID: 17368522
[TBL] [Abstract][Full Text] [Related]
16. Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?
Petignat P; du Bois A; Bruchim I; Fink D; Provencher DM
Crit Rev Oncol Hematol; 2007 May; 62(2):137-47. PubMed ID: 17188887
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis.
Bristow RE; Santillan A; Salani R; Diaz-Montes TP; Giuntoli RL; Meisner BC; Armstrong DK; Frick KD
Gynecol Oncol; 2007 Sep; 106(3):476-81. PubMed ID: 17688927
[TBL] [Abstract][Full Text] [Related]
18. Intraperitoneal chemotherapy for ovarian cancer: where are we now?
Singhal P; Lele S
J Natl Compr Canc Netw; 2006 Oct; 4(9):941-6. PubMed ID: 17020670
[TBL] [Abstract][Full Text] [Related]
19. Advanced cancer of the ovary: intraperitoneal chemotherapy as a new therapeutical option.
Fiorentini G; Filippeschi M; Turrisi G; Mambrini A; Giannessi PG; D'Alessandro M; Rossi S; Dentico P; Guadagni S; Cantore M; Madrigali A
In Vivo; 2009; 23(2):317-21. PubMed ID: 19414421
[TBL] [Abstract][Full Text] [Related]
20. [Intraperitoneal chemotherapy for ovarian cancer].
Noma J; Yoshida N
Gan To Kagaku Ryoho; 2008 Jun; 35(6):885-90. PubMed ID: 18633214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]